FEATURED ARTICLES
-
DEA Reveals Hidden Costs Of Analytical Validation Guidelines
By treating distinct validation guidelines as decision-making units, data envelopment analysis (DEA) allows for the mathematical evaluation of their resource efficiency.
WHITE PAPERS & CASE STUDIES
-
Reduce Complexity, Not Quality In CAR T Cell Manufacturing
Fragmented CAR T cell manufacturing workflows drive up costs and extend timelines. This case study quantifies what consolidating manufacturing and QC through automation actually delivers.
-
Developing A Science- And Risk-Based Bio-Decontamination Control Strategy For Pharmaceutical Isolators
Modern contamination control links barrier design, bio-decontamination science, and risk-based validation to ensure reliable surface sterility.
-
FM Approval Standard 4882
A fire in a pharmaceutical cleanroom can be contained, but for sterile manufacturers, smoke can turn a localized event into a far wider decontamination, requalification, and production-recovery challenge.
-
The Strategic Value Of In-House Delumping For Homogeneous API Production
API batch homogeneity supports efficient manufacturing. Controlled delumping improves powder flow and chargeability while maintaining particle size integrity and reducing GMP-scale risks.
-
Enhancing Quality And Environmental Monitoring Efficiency Through Paperless Sampling
At roughly 600,000 samples per year, manual EM documentation creates real compliance and operational risk. This whitepaper details how a fully integrated digital sampling system addresses both.
-
Digital CMC Maturity: Rethinking QTTP And Control Strategy
Digital CMC maturity depends on structured, science- and risk-based knowledge. Learn how connecting development, validation, regulatory, and lifecycle information can accelerate timelines.